• Explore /
  • Poster
  • / Phase II trial of carfilzomib and irinotecan in relapsed small cell lung cancer (NCT01941316).

Phase II trial of carfilzomib and irinotecan in relapsed small cell lung cancer (NCT01941316).

Abstract Poster

Authors

Susanne Arnold

Susanne M. Arnold

Markey Cancer Center, University of Kentucky, Lexington, KY

Susanne M. Arnold , Kari Chansky , Maria Quintos Baggstrom , Michael A. Thompson , Rachel E. Sanborn , John Villano , Saiama Naheed Waqar , John Turner Hamm , Mark Leggas , Maurice Willis , Joseph G Rosales , John Crowley

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Small Cell Lung Cancer

Clinical Trial Registration Number

NCT01941316

Citation

J Clin Oncol 37, 2019 (suppl; abstr 8513)

DOI

10.1200/JCO.2019.37.15_suppl.8513

Abstract #

8513

Poster Bd #

269

Abstract Disclosures

Similar Posters

First Author: Dong Ho Lee

First Author: Jie Xu

First Author: Jun Ni

First Author: Konstantinos Leventakos